From Research to Recommendation
We believe in the scientific clarity that comes from careful analysis of all available data. To offer clinical guidance and perform our comparative analyses, we draw upon the most recent, high quality clinical data. The result is a comprehensive, precise, and accurate comparison of therapeutic choices to provide patients and clinicians with the best available evidence.
Our analyses cover a variety of therapeutic areas, including psychiatric disorders, cardiometabolic disorders, neurology, pediatrics, pain, and infectious disease. We customize our analyses to answer the questions posed by our clients.
Recent Analysis
Multiple Sclerosis
Survey
Multiple sclerosis (MS) is a degeneration neurological condition that can impact all aspects of a person's life. We polled 350 people across the United States on their views of MS, including which symptoms they believe are the most significant and how they would try to learn more about the disease.
Depression Survey
Depression is a serious mental illness that impacts the lives of millions of Americans. We asked people from across the country about their experience with depression, which symptoms they believe are the most debilitating, and their thoughts on the challenges of managing the disease.
Clinical Trial Transparency
Access to the all clinical data is an important part of evidence-based medicine. But despite publication guidelines and best practices, many clinical trials sponsored by industry remain unpublished. We reviewed clinical trials and publication databases to determine publication rates across therapeutic areas.
Type 2 Diabetes
There are plenty of therapies available, but no two treatments are the same. We analyzed efficacy measures from recent label claims of type 2 diabetes treatments to determine which compounds had the greatest impact across multiple outcomes.
Bipolar Disorder
Lithium has been used in bipolar disorder for years, but our understanding of dosing may require another look. We reviewed clinical trials and treatment guidelines to determine how to balance efficacy and safety in adult patients.
Child Psychiatry
Atypical antipsychotics are widely used in young patients, but these drugs are associated with with adverse events. We studied recent data to find out how available compounds affect weight in pediatric patients.